Barometer Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-304,642
Closed -$22.4M 133
2016
Q2
$22.4M Buy
304,642
+295,700
+3,307% +$20.9M 2.22% 15
2016
Q1
$571K Sell
8,942
-71,758
-89% -$4.53M 0.06% 129
2015
Q4
$5.55M Buy
+80,700
New +$5.33M 0.54% 46
2015
Q3
Sell
-232,200
Closed -$15.5M 125
2015
Q2
$15.5M Sell
232,200
-261,100
-53% -$17.2M 1.26% 30
2015
Q1
$31.8M Sell
493,300
-118,500
-19% -$7.42M 2.46% 15
2014
Q4
$36.1M Buy
+611,800
New +$34.5M 3.17% 13

Other funds holding BMY

Barometer Capital Management's BMY Position: Q3 2016 in Review

Barometer Capital Management sold out of Bristol-Myers Squibb (BMY) in Q3 2016, closing a stake of 304,642 shares — an estimated $22.4M sold.

Barometer Capital Management first reported a position in BMY in Q4 2014 and held it in 6 quarters. The position peaked at $36.1M in Q4 2014. 1,523 funds tracked by Wall St. Rank hold BMY as of Q3 2016.

  • Barometer Capital Management reported no remaining Bristol-Myers Squibb position as of Q3 2016 after selling out during the quarter.
  • Barometer Capital Management sold 304,642 Bristol-Myers Squibb shares in Q3 2016, an estimated $22.4M.
  • Barometer Capital Management first reported a position in Bristol-Myers Squibb in Q4 2014 and held it in 6 quarters.
  • Barometer Capital Management's Bristol-Myers Squibb position peaked at $36.1M in Q4 2014.
  • 1,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2016.

Based on Barometer Capital Management's 13F filing for Q3 2016, filed 9 Nov 2016.